Skip to content
Trial Eligibility
Menu

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

NCT05276050

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from F8 coil or active rTMS from H coil for smoking cessation. Smoking and brain functional connectivity changes will be assessed at baseline, different stages of rTMS and/or follow-ups.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Smoking Cessation
  • Nicotine Addiction
  • Schizophrenia

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
The University of Texas Health Science Center, Houston
Last updated on ClinicalTrials.gov
September 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • The University of Texas Health Science Center, Houston · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.